fbpx
Skip to main content

Nationals pitcher Joe Ross to have second Tommy John surgery

Aug 5, 2021; Washington, District of Columbia, USA; Washington Nationals starting pitcher Joe Ross (41) throws to the Philadelphia Phillies during the seventh inning at Nationals Park. Mandatory Credit: Brad Mills-USA TODAY Sports
Brad Mills-USA TODAY Sports

Washington Nationals RHP Joe Ross will undergo Tommy John surgery for the second time in his career following a recent setback during a rehab assignment, manager Dave Martinez said Tuesday.

Ross, 29, first underwent the elbow surgery in July 2017, and returned to pitch for the Nationals in September of 2018. Last season, he matched his career high with 19 starts and had a 5-9 record with a 4.17 ERA before he sustained a partially torn ulnar collateral ligament in August.

He and the team chose a non-surgical rehab course and in March he underwent a less-substantial cleanup surgery to remove bone spurs in his elbow.

Ross had been anticipating a June return to the Nationals’ rotation when he went to Class AA Harrisburg last week for his first rehab assignment. He pitched three innings and left the game with elbow tightness, and an MRI revealed more ligament damage.

“He got different opinions, and they all came back to say that he needed surgery,” Martinez said Tuesday.

Although Martinez did not indicate a timeline, full Tommy John surgery typically requires 14-16 months of recovery.

While Tommy John surgery has become common, a second procedure and the accompanying long rehabilitation has been far less frequent — Mike Clevenger of the San Diego Padres and Nathan Eovaldi of the Boston Red Sox are two current pitchers who have endured the surgery twice and returned successfully to the major leagues.

Ross was a first-round draft pick of the Padres in 2011 and was traded to the Nationals in 2014. He has appeared in 98 games in his career, including 76 starts, with a 26-28 record, a 4.26 ERA and 403 strikeouts in 443 innings.

–Field Level Media

Mentioned in this article:

More About: